In Brief: NDMA on FDA reform
This article was originally published in The Tan Sheet
Executive Summary
NDMA on FDA reform: NDMA representatives recently met with Senate and House staffers to present the association's views on FDA reform. NDMA said it is seeking provisions that would preserve the existence of FDA's Office of OTC Drugs and would enhance the agency's processing of Rx-to-OTC switch applications and supplemental NDAs. NDMA also is interested in including a provision that would ensure national uniformity for OTC drugs...